According to the IMARC Group, the global artificial pancreas device systems market to exhibit a CAGR of around 18% during 2020-2025. An artificial pancreas device system (APDS) refers to an autonomous system for glycemic control. It consists of a continuous glucose monitoring system (CGM), an insulin infusion pump and a blood glucose device for calibrating CGM. The […]